Acadia Pharma Stock Price (NASDAQ:ACAD)

Add to My Stocks
$34.83 $0.38 (1.1%) ACAD stock closing price Mar 24, 2017 (Closing)
YOUR DAILY UPDATE ON
ACAD
Acadia Pharma
24 MAR 2017
amigobulls logo
ACAD hand_up
ACAD vs S&P 500
Closing Price: Mar 24, 2017
ACAD
$34.83 ( 1.1%)
S&P 500
2344 ( -0.08%)
ACAD
52 Week Price Range
1 Year Return: 69.62%
Q4 Growth*
Excellent
Profitable ?
No
net image
2016 Q4 Net Loss
-1566%
home image
Rating
ACAD POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Acadia Pharma Snapshot Video

27 5 2

ACAD Stock Details

Prev Close* : $34.45
Market Cap:
$4.18B
Day Low: $34.19
52 Week Low: $19.32
Open: $34.58
Volume: 1209729
Day High: $35
52 Week High: $42.49
Dividend:
N/A

Latest Stock Market News

Latest Articles

Acadia Pharma News - From Partners

ACAD Stockcharts

View ACAD PE ratio, PS ratio stocks charts and compare with peers.
ACAD Chart
Note: Compare Acadia Pharma stock price history with the index and industry peers.

Acadia Pharma Valuation

PS ratio (
price to sales ratio
)
243.59
PB ratio (
price to book ratio
)
9.82

Acadia Pharma Financial Ratios

Asset Turnover
0.04
Receivables Turnover
2.85

ACAD Industry Peers

Company Price Change (%)
Bioverativ Inc (BIVV)50.30.17 (0.34%)
Kite Pharma (KITE)76.842.34 (3.14%)
Eli Lilly (LLY)84.180.24 (0.28%)
Pfizer (PFE)340.29 (0.85%)
Adamas Pharma (ADMS)17.460 (0%)
Axsome Therapeutics (AXSM)3.650.05 (1.35%)
Praxsyn (PXYN)0.010 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Enzo Biochem (ENZ)8.430.52 (6.57%)
Peregrine Pharma (PPHM)0.7060.03 (4.44%)
Ophthotech (OPHT)3.530.15 (4.44%)
Kindred Biosciences (KIN)7.20.3 (4.35%)
Fortress Biotech (FBIO)3.60.14 (4.05%)
Immunomedics (IMMU)6.880.25 (3.77%)
Compugen (CGEN)4.350.15 (3.57%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)1.750.18 (9.35%)
Vital Therapies (VTL)3.850.15 (3.75%)
MannKind (MNKD)1.890.06 (3.08%)
PDL BioPharma (PDLI)1.980.05 (2.46%)
Sangamo BioSciences (SGMO)4.10.1 (2.38%)
Sorrento Therapeutics (SRNE)4.10.1 (2.38%)
Ultragenyx Pharma (RARE)70.321.67 (2.32%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017

ACADIA Pharmaceuticals Inc. Stock News - Partner Headlines

Acadia Pharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues0.06M0.12M1.14M4.9M2.06M
Net Income-164.44M-92.47M-37.94M-20.84M-22.76M
Total Operating Expense164.66M93.34M39.44M25.78M24.91M
view ACADIA Pharmaceuticals Inc. income statement
balance sheet20152014201320122011
Total Assets221.89M325.45M189.11M108.59M32.11M
Total Liabilities22.13M15.96M6.98M23.6M8.75M
Shareholders Equity199.76M309.48M182.13M84.98M23.36M
view ACADIA Pharmaceuticals Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities4.11M9.31M-1.12M-2.43M0.07M
Net Cash From (Used By) Operating Activities-121.79M-66.43M-31.76M-21.63M-19.89M
Increase (Decrease) In Prop Plant And Equipment-2.14M-0.18M-0.6M0.25M-
view ACADIA Pharmaceuticals Inc. cashflow statement

Acadia Pharma Stock Message Board

Acadia Pharma stock lost 1.1 %, and the last close price as of 24 Mar, 2017 is 34.83 for ACAD stock. Acadia Pharma market capitalization is 4.18B and it represents the total market value of ACAD stock. Acadia Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy ACAD stock than sell it, then Acadia Pharma stock price goes up. Conversely, if more investors wanted to sell ACAD stock than buy it, there would be greater supply than demand, and the stock price would fall. 1209729 shares were traded with a closing stock price of 34.83 as of 24 Mar, 2017, as can be seen from Acadia Pharma stock quote. One can view Acadia Pharma stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Acadia Pharma stock price history, gives the entire historical data for ACAD stock.